Biosimilar Newsletter Archive

1. 04.17.25 -- AI Performance Management In Biologic And Drug Development 4/17/2025
   04/17/25 Biosimilar Development Newsletter
2. 04.10.25 -- U.S. Biosimilars Surge: Clinical Trials, Regulatory Shifts, And The Path To Dominance 4/10/2025
   04/10/25 Biosimilar Development Newsletter
3. 04.03.25 -- Optimize Downstream Separation With Tagless Proteins 4/3/2025
   04/03/25 Biosimilar Development Newsletter
4. 03.27.25 -- Challenges & Opportunities Of Outsourcing Biopharma Development 3/27/2025
   03/27/25 Biosimilar Development Newsletter
5. 03.26.25 -- De-Risk The Transfer of Process and Product Knowledge With an Experienced CDMO 3/26/2025

   03/26/25 Biosimilar Development Newsletter

6. 03.20.25 -- Discover How To Optimize Productivity In Your mAb Capture 3/20/2025
   03/20/25 Biosimilar Development Newsletter
7. 03.20.25 -- Comparison Of WFI Production Methods 3/20/2025
   03/20/25 Biosimilar Development Newsletter
8. 03.13.25 -- Optimize Your High Concentration Biologic Production Process 3/13/2025

   03/13/25 Biosimilar Development Newsletter

9. 03.13.25 -- Emerging Trends In mAbs Manufacturing 3/13/2025
   03/13/25 Biosimilar Development Newsletter
10. 03.06.25 -- Clinical Regulatory Changes One of Many Tailwinds for Biosimilars 3/6/2025
    03/06/25 Biosimilar Development Newsletter